Skip to main content

Bayer (0P6S) Gets a Buy from J.P. Morgan

Tipranks - Tipranks - Tue Mar 10, 3:46AM CDT

In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Bayer, with a price target of €50.00.

Claim 70% Off TipRanks Premium

According to TipRanks, Vosser is a 3-star analyst with an average return of 0.9% and a 46.78% success rate. Vosser covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Sanofi, and Novo Nordisk.

In addition to J.P. Morgan, Bayer also received a Buy from Barclays’s Charles Pitman CFA in a report issued today. However, on March 6, TipRanks – OpenAI reiterated a Hold rating on Bayer (LSE: 0P6S).

See the top stocks recommended by analysts >>

The company has a one-year high of €49.78 and a one-year low of €18.38. Currently, Bayer has an average volume of 3.86M.

Based on the recent corporate insider activity of 9 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of 0P6S in relation to earlier this year.

Read More on GB:0P6S:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).